A formulation for pain management is provided comprising cannabichromene as the primary cannabinoid together with an excipient and, optionally, one or more secondary cannabinoids in an amount of up to 5% by weight of the primary cannabinoid. The formulation is essentially free of tetrahydrocannabinol. The types of pain to be managed with the formulation include but are not limited to the treatment of neuropathic pain, pain due to cancer, injury, accident, surgery, or tissue damage. Methods of use of the formulation, doses and dosage forms are described.

Disclosed is a personal vaping device provided with an electrical heating module as an atomizer or heater. The personal vaping device at least includes a power control circuit, which includes a current input terminal, a current input terminal, and a current control module. The power control circuit further includes a power supply control module, a current control module, a voltage modulation module, and a forward and reverse connection current generation module. The microprocessor is configured to control the voltage modulation module and the forward and reverse connection current generation module. The voltage modulation module is configured to regulate a voltage of the DC power supply to a first target voltage and a second target voltage. The forward and reverse connection current generation module is configured to generate a forward connection current and a reverse connection current according to the second target voltage to drive the atomizer or heater for heating.

A method for coating a paper drinking straw, an apparatus for coating a paper drinking straw, and a coated drinking straw assembly are disclosed. The apparatus includes a dipping tank containing a liquid bath for coating a straw when submerged in the liquid and a straw engagement means for submerging the straw in the bath. The method includes receiving an uncoated paper drinking straw and submerging the straw in a bath containing a water-resistant and/or a water-soluble coating. The drinking straw assembly includes an elongate tubular body and a coating that has been applied to all surfaces of the straw by submerging the body in a bath containing the coating.

The present invention discloses use of a cannabinoid compound or pharmaceutically available salts thereof in preparation of a pharmaceutical composition for treatment of neurodermatitis, wherein the cannabinoid compound may be one selected from the group consisting of tetrahydrocannabinol, cannabidiol, cannabidivarin and tetrahydrocannabinovarin, or selected from the group consisting of: (1) a combination of tetrahydrocannabinol and tetrahydrocannabinovarin; (2) a combination of cannabidiol and cannabidivarin; (3) a combination of tetrahydrocannabinol and cannabidivarin; (4) a combination of cannabidiol and tetrahydrocannabinovarin; (5) a combination of cannabidiol, cannabidivarin, and tetrahydrocannabinovarin; (6) a combination of tetrahydrocannabinol, cannabidivarin, and tetrahydrocannabinovarin.

The present invention discloses use of a cannabinoid compound or pharmaceutically available salts thereof in preparation of a pharmaceutical composition for treatment of neurodermatitis, wherein the cannabinoid compound may be one selected from the group consisting of tetrahydrocannabinol, cannabidiol, cannabidivarin and tetrahydrocannabinovarin, or selected from the group consisting of: (1) a combination of tetrahydrocannabinol and tetrahydrocannabinovarin; (2) a combination of cannabidiol and cannabidivarin; (3) a combination of tetrahydrocannabinol and cannabidivarin; (4) a combination of cannabidiol and tetrahydrocannabinovarin; (5) a combination of cannabidiol, cannabidivarin, and tetrahydrocannabinovarin; (6) a combination of tetrahydrocannabinol, cannabidivarin, and tetrahydrocannabinovarin.

The present invention provides compositions for solubilizing water-insoluble and poorly water-soluble or poorly permeable active ingredients such as drugs, nutritional supplements, and essential oils. The compositions are useful for administration of the active ingredient to the subject via various routes and provide good bioavailability of the active. The compositions are generally clear and non-turbid and are useful, for example, for preparing formulations of cannabinoid compounds.

Packaged hemp products formed from raw cannabis are provided. In one example, frozen hemp cubes or frozen hemp ice pops are provided. First, raw cannabis material is collected and blended to form hemp juice purée. Next, the hemp juice purée is poured into molds for manufacturing frozen hemp cubes or into tube-shaped containers for manufacturing frozen hemp ice pops, and the hemp juice purée is frozen. In another example, packaged hemp juice purée is formed by collecting raw cannabis material, blending the material to obtain hemp juice purée, and packaging the hemp juice purée using high pressure processing (HPP). In yet another example, hemp powder is formed by collecting raw cannabis material, drying out the raw cannabis material, and grinding the dried raw cannabis material to obtain a hemp powder. The hemp powder is packaged and provided along with instructions.

Disclosed herein are compositions capable of enhanced delivery and absorption of biologically active agents when administered to a subject. Further disclosed are methods for increasing the in vivo absorption of biologically active agents.

Disclosed herein are compositions capable of enhanced delivery and absorption of biologically active agents when administered to a subject. Further disclosed are methods for increasing the in vivo absorption of biologically active agents.

The invention relates to a THC-free cannabinoid concentrate, method of obtaining the same and use thereof. The method of obtaining comprises an alkaline wash to purify lipid extracts.